scholarly journals Cyclophosphamide-Associated Reversible Cerebral Vasoconstriction Syndrome Presenting as Concurrent Cerebral Infarction and Subarachnoid Hemorrhage

2021 ◽  
Vol 39 (3) ◽  
pp. 202-206
Author(s):  
Dong-Young Jeong ◽  
Keon-Woo Kim ◽  
Yun-Jik Park ◽  
Yeon-Jung Kim ◽  
Jun Young Chang

Reversible cerebral vasoconstriction syndrome (RCVS) has several trigger factors, including physical exertion, pregnancy, and the intake of vasoconstrictive agents. These triggers activate the sympathetic nervous system and induce vasoconstriction, thereby leading to an ischemic or hemorrhagic stroke. In this study, we describe case of RCVS in a 73-year-old woman who complained of sudden bilateral leg weakness after taking cyclophosphamide for anti-neutrophil cytoplasmic antibody associated vasculitis. She was diagnosed with concurrent cerebral hemorrhage and cerebral infarction with multiple intracranial vasoconstrictions on imaging analyses.

Nosotchu ◽  
2019 ◽  
Vol 41 (3) ◽  
pp. 177-181
Author(s):  
Tatsuya Mori ◽  
Atsushi Arai ◽  
Kazuhiro Tanaka ◽  
Taichiro Imahori ◽  
Ryoji Shiomi ◽  
...  

Author(s):  
Ji Y. Chong ◽  
Michael P. Lerario

Reversible cerebral vasoconstriction syndrome can cause thunderclap headache, subarachnoid hemorrhage, and stroke. The clinical presentation can be similar to aneurysmal subarachnoid hemorrhage and therefore requires rapid angiography. Angiographic findings of vasculopathy and resolution of clinical symptoms and imaging abnormalities support this diagnosis. This syndrome is most often incited following pregnancy or the ingestion of a vasoactive medication.


Sign in / Sign up

Export Citation Format

Share Document